Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Two-step immunological approaches for imaging and therapy

S F Rosebrough1

  • 1Department of Radiology, University of Rochester, New York, USA.

The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)
|September 1, 1996
PubMed
Summary

Radiolabeled antibodies improve imaging and therapy but face challenges. New methods using bispecific antibodies or streptavidin systems enhance clearance, reducing background and improving target visibility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isothiocyanate-trigalactose: application for antibody-targeted delivery of diagnostic and therapeutic agents.

Cancer biotherapy & radiopharmaceuticals·2001
Same author

Biochemical modification of streptavidin and avidin: in vitro and in vivo analysis.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1996
Same author

Galactose-modified streptavidin-GC4 antifibrin monoclonal antibody conjugates: application for two-step thrombus/embolus imaging.

The Journal of pharmacology and experimental therapeutics·1996
Same author

Pharmacokinetics and biodistribution of 131I-labeled trigalactose conjugate of streptavidin.

Drug metabolism and disposition: the biological fate of chemicals·1996
Same author

Synthesis, pharmacokinetics, and biodistribution of 67GA deferoxamineacetyl-cysteinylbiotin.

Drug metabolism and disposition: the biological fate of chemicals·1995
Same author

Quantification and lowering of serum biotin.

Laboratory animal science·1995

Area of Science:

  • Biomedical imaging
  • Radiopharmaceutical therapy
  • Molecular biology

Background:

  • Radiolabeled antibodies (mAbs) and fragments are used in imaging and therapy.
  • Prolonged circulation and organ accumulation cause high background and delayed imaging.
  • Current multi-step methods involve targeting moieties and radiolabeled agents.

Purpose of the Study:

  • To review advanced strategies for improving radiolabeled antibody applications.
  • To address challenges of high background and suboptimal imaging times.
  • To focus on bispecific mAbs and mAb-streptavidin/biotin systems.

Main Methods:

  • Review of bispecific monoclonal antibodies for targeted delivery.
  • Examination of the streptavidin (avidin)/biotin system in antibody-based approaches.

Related Experiment Videos

  • Analysis of strategies for rapid clearance of radiolabeled agents.

    • Main Results:

    • Two- and three-step procedures enhance targeting and reduce background.
    • Rapid blood clearance of free radiolabeled agents minimizes radiation dose.
    • Improved target-to-background ratios are achieved.

    Conclusions:

    • Bispecific antibodies offer a promising approach for targeted radioimmunotherapy and imaging.
    • The streptavidin/biotin system provides an effective platform for enhanced radiopharmaceutical delivery.
    • These advanced methods overcome limitations of traditional radiolabeled antibodies, improving diagnostic and therapeutic outcomes.